Dr. Kärt Tomberg is a Sir Henry Wellcome Postdoctoral Fellow at The Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID) working in Prof. Allan Bradley’s laboratory.
Since the start of the pandemic, Kärt has shifted all her efforts towards understanding the SARS-Cov-2 virus as a co-Investigator on a UKRI COVID-19 grant ‘Identification of host cell components essential for the SARS-CoV-2 life cycle’.
Kärt received both her Bachelor’s and Master’s degrees from the University of Tartu in her native Estonia. In 2010, she joined Prof. David Ginsburg’s lab at the Department of Human Genetics, University of Michigan as a Fulbright Science and Technology Fellow to work on her PhD thesis. After graduating in 2016, Kärt spent a year travelling through Central and South America while finishing up papers and writing grants before joining Prof. Allan Bradley’s lab for her postdoctoral work.